Home » Stocks » SYNH

Syneos Health, Inc. (SYNH)

Stock Price: $53.08 USD -1.06 (-1.96%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed
After-hours: $60.45 +7.37 (13.89%) Oct 30, 5:39 PM

Stock Price Chart

Key Info

Market Cap 5.55B
Revenue (ttm) 4.49B
Net Income (ttm) 191.95M
Shares Out 104.00M
EPS (ttm) 1.83
PE Ratio 29.01
Forward PE 15.38
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $53.08
Previous Close $54.14
Change ($) -1.06
Change (%) -1.96%
Day's Open 54.29
Day's Range 52.29 - 55.93
Day's Volume 879,100
52-Week Range 30.02 - 74.25

More Stats

Market Cap 5.55B
Enterprise Value 8.11B
Earnings Date (est) Mar 3, 2021
Ex-Dividend Date n/a
Shares Outstanding 104.00M
Float 69.07M
EPS (basic) 1.85
EPS (diluted) 1.83
FCF / Share 4.03
Dividend n/a
Dividend Yield n/a
Earnings Yield 3.45%
FCF Yield 7.57%
Payout Ratio n/a
Shares Short 5.74M
Short Ratio 5.14
Short % of Float 8.30%
Beta 1.74
PE Ratio 29.01
Forward PE 15.38
P/FCF Ratio 13.21
PS Ratio 1.24
PB Ratio 1.85
Revenue 4.49B
Operating Income 241.89M
Net Income 191.95M
Free Cash Flow 419.89M
Net Cash -2.57B
Net Cash / Share -24.58
Gross Margin 22.94%
Operating Margin 5.39%
Profit Margin 4.30%
FCF Margin 9.35%
ROA 2.85%
ROE 6.44%
ROIC 6.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (15)

Buy 10
Overweight 1
Hold 4
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$74.38*
(40.13% upside)
Low
65.0
Current: $53.08
High
84.0
Target: 74.38
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue4,6764,3902,6721,6111,3991,179995869656
Revenue Growth6.51%64.3%65.91%15.11%18.7%18.46%14.56%32.41%-
Gross Profit1,030956621404372295220190157
Operating Income214188-48.7114615263.6431.46-37.53-40.20
Net Income13124.28-138113117-23.47-41.53-59.11-59.55
Shares Outstanding10410374.9154.0357.8953.3052.0152.2043.88
Earnings Per Share1.250.23-1.852.031.95-0.51-0.81-1.14-1.46
EPS Growth443.48%--4.1%-----
Operating Cash Flow31830319810920513137.2743.00-18.53
Capital Expenditures-63.97-54.60-43.90-31.35-21.11-25.55-17.71-9.59-4.76
Free Cash Flow25524915478.1418410619.5633.41-23.30
Cash & Equivalents16415632210385.4612797.5482.41-
Total Debt2,9202,8283,008498502416594594-
Net Cash / Debt-2,756-2,672-2,686-395-416-289-497-512-
Assets7,4547,2557,2861,2891,2111,2411,2331,258-
Liabilities4,4244,3994,263987994849957941-
Book Value3,0302,8563,023301217392276317-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Syneos Health, Inc.
Country United States
Employees 24,000
CEO Alistair John Macdonald

Stock Information

Ticker Symbol SYNH
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: SYNH
IPO Date November 7, 2014

Description

Syneos Health operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.